帕金森病大鼠腸功能障礙及血清腦腸肽與腦內(nèi)酪氨酸羥化酶相關(guān)性研究
[Abstract]:Objective: to observe the behavioral changes and gastrointestinal dysfunction in PD rats induced by rotenone, and to determine the cholecystokinin (CCK), in serum. The correlation between the content of new fat factor (Nesfatin-1) and the average optical density of tyrosine hydroxylase (TH) in nigra striatum to study whether brain intestinal peptide can be used as an early diagnostic index of PD. The changes of average optical density of TH at different time and different sites were measured to explore the early pathogenesis of PD. Methods: 84 rats were randomly divided into experimental group (n = 42) and solvent group (n = 42). The experimental group was injected with rotenone sunflower oil emulsion (2mg/ml) subcutaneously, and the solvent group was injected with the same volume sunflower oil emulsion for 0 weeks. The rats' body weight, step test and suspension test, the percentage of fecal water content and the percentage of gastric contents in body weight were measured by immunohistochemical method after 30 minutes of injection for 2 weeks, 4 weeks and 6 weeks. The mean optical density of tyrosine hydroxylase (TH) in thoracic spinal cord and nigra striatum was measured by ELISA. The contents of CCK and Nesfatin-1 in brain intestine were determined by ELISA method. The relationship between serum CCK,Nesfatin-1 and TH in brain was analyzed by Pearson assay. Results: the behavior test showed that the weight of the experimental group was significantly lower than that of the solvent group (P0.05). The scores of suspension test in the experimental group were significantly decreased (P0.05), especially in the 4th week of the experiment group, but the degree of the decrease was slower after 4 weeks. The number of stride in the experimental group was significantly decreased (P0.05), while the weight of the rats in the solvent group was significantly decreased (P0.05), and the weight of the rats in the solvent group was significantly lower than that in the control group. There was no significant change in suspension test and step test (P0.05). The percentage of fecal water content and gastric contents in body weight was significantly decreased (P0.05) and the percentage of gastric contents in body weight was significantly increased (P0.05) in the experimental group from the second week. Compared with the solvent group, the content of CCK and Nesfatin-1 in the serum of the experimental group increased significantly from the second week (P0.05), and the content of Nesfatin-1 decreased gradually after 6 weeks. No significant change was found in the solvent group (P0.05). The results of immunohistochemistry showed that the average optical density of TH in rectum, thoracic pulp and striatum of nigra decreased significantly in the experimental group (P0.05), and the rectum showed a more obvious downward trend from the second week. However, the mean optical density of TH in the intestinal tract, thoracic spinal cord and substantia nigra was not significantly changed in the solvent group (P0.05). From the dynamic changes of serum CCK content and TH optical density in the brain of experimental rats, it was found that there was a negative correlation between the two changes with time (P0.05). There was no significant correlation between the content of Nesfatin-1 in serum and the average optical density of TH in nigra striatum in the experimental group (P0.05). Conclusion: the level of CCK in serum of Parkinson's disease rats was significantly increased at the early stage, which was negatively correlated with dopaminergic neurons in the brain, suggesting that serum CCK may be used as a predictor of early PD.
【學位授予單位】:南華大學
【學位級別】:碩士
【學位授予年份】:2016
【分類號】:R742.5
【參考文獻】
相關(guān)期刊論文 前10條
1 石麗敏;姜宏;謝俊霞;;帕金森病和阿爾茨海默病中Ghrelin的神經(jīng)保護作用研究進展[J];生理科學進展;2014年02期
2 Wei Huang;Shu-Man Jiang;Lin Jia;Le-Qing You;Yao-Xing Huang;Yan-Mei Gong;Gui-Qin Wang;;Effect of amitriptyline on gastrointestinal function and brain-gut peptides: A double-blind trial[J];World Journal of Gastroenterology;2013年26期
3 朱鏞連;;神經(jīng)遞質(zhì)與疾病和藥物康復[J];中國康復理論與實踐;2011年02期
4 李林;張博愛;;帕金森病的消化系統(tǒng)功能紊亂[J];國際神經(jīng)病學神經(jīng)外科學雜志;2010年06期
5 趙喜林,顧振綸,秦正紅;長期低劑量皮下注射魚藤酮制作大鼠帕金森病模型[J];中國藥理學通報;2005年10期
6 馬曉凱,范凱;P物質(zhì)與帕金森病[J];大連醫(yī)科大學學報;2005年02期
7 李云鵬,董兆君,王仕麗,蔡穎,李奇慧,樂衛(wèi)東;重復注射魚藤酮對中樞多巴胺神經(jīng)元的毒性作用[J];第三軍醫(yī)大學學報;2003年13期
8 陳大慶,倪宏;縮膽囊素生物學作用的多樣性[J];國外醫(yī)學(兒科學分冊);2002年03期
9 ;乙醇心血管保護作用的潛在機制(英文)[J];Acta Pharmacologica Sinica;2000年05期
10 謝俊霞,孫朝暉,蔣正堯,唐明;CCK-8及損毀MFB對腹側(cè)被蓋區(qū)和伏核多巴胺、CCK-8含量的影響[J];中國神經(jīng)科學雜志;2000年01期
相關(guān)會議論文 前1條
1 欒守婧;付文玉;莊文欣;馬璐璐;王曉曉;;帕金森病大鼠中縫背核5-HT、NPY、SP蛋白及mRNA的表達變化[A];中國解剖學會2013年年會論文文摘匯編[C];2013年
相關(guān)博士學位論文 前2條
1 陳路;培補肝腎復方治療帕金森病及其腸功能障礙的療效研究[D];北京中醫(yī)藥大學;2013年
2 沈曉麗;Nesfatin-1對多巴胺能神經(jīng)元的保護作用及機制探討[D];青島大學;2014年
相關(guān)碩士學位論文 前1條
1 何珊;帕金森病模型大鼠腦內(nèi)TH表達變化的實驗研究[D];揚州大學;2014年
,本文編號:2390934
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2390934.html